Scott Wiseman

625 total citations
34 papers, 450 citations indexed

About

Scott Wiseman is a scholar working on Parasitology, Infectious Diseases and Small Animals. According to data from OpenAlex, Scott Wiseman has authored 34 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Parasitology, 19 papers in Infectious Diseases and 12 papers in Small Animals. Recurrent topics in Scott Wiseman's work include Dermatological diseases and infestations (12 papers), Helminth infection and control (11 papers) and Vector-borne infectious diseases (9 papers). Scott Wiseman is often cited by papers focused on Dermatological diseases and infestations (12 papers), Helminth infection and control (11 papers) and Vector-borne infectious diseases (9 papers). Scott Wiseman collaborates with scholars based in United States, United Kingdom and Italy. Scott Wiseman's co-authors include Daniel E. Snyder, Jason Drake, I. P. Wright, Julian Liebenberg, Larry R. Cruthers, Craig R. Reinemeyer, Dwight D. Bowman, Steve Nanchen, Martin Murphy and Daniela Cavalleri and has published in prestigious journals such as The Journal of Physical Chemistry A, SAE technical papers on CD-ROM/SAE technical paper series and Energies.

In The Last Decade

Scott Wiseman

29 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Wiseman United States	14	256	244	127	107	102	34	450
Robert H. Six United States	18	482 1.9×	519 2.1×	184 1.4×	85 0.8×	110 1.1×	36	696
Aleah Pullins United States	11	199 0.8×	193 0.8×	85 0.7×	78 0.7×	73 0.7×	15	342
Dhimitër Rapti Albania	13	364 1.4×	272 1.1×	102 0.8×	121 1.1×	96 0.9×	24	517
Wendell L. Davis United States	14	290 1.1×	199 0.8×	147 1.2×	44 0.4×	71 0.7×	26	423
Julian Liebenberg South Africa	12	281 1.1×	337 1.4×	183 1.4×	19 0.2×	34 0.3×	35	473
W. Tarello Italy	11	205 0.8×	229 0.9×	45 0.4×	65 0.6×	23 0.2×	39	379
R. G. Arther United States	14	255 1.0×	284 1.2×	119 0.9×	118 1.1×	90 0.9×	26	415
Ilir Kusi Albania	10	259 1.0×	241 1.0×	74 0.6×	75 0.7×	71 0.7×	11	421
D.J Shanks United Kingdom	12	156 0.6×	201 0.8×	62 0.5×	35 0.3×	142 1.4×	16	335
Mariasole Colombo Italy	10	183 0.7×	148 0.6×	135 1.1×	120 1.1×	103 1.0×	36	324

Countries citing papers authored by Scott Wiseman

Since Specialization

Citations

This map shows the geographic impact of Scott Wiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Wiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Wiseman more than expected).

Fields of papers citing papers by Scott Wiseman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Wiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Wiseman. The network helps show where Scott Wiseman may publish in the future.

Co-authorship network of co-authors of Scott Wiseman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Wiseman. A scholar is included among the top collaborators of Scott Wiseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Wiseman. Scott Wiseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiseman, Scott, et al.. (2025). Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs. Parasites & Vectors. 18(1). 153–153. 1 indexed citations

Charles, Samuel, Katrin Deuster, Scott Wiseman, et al.. (2025). Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs. Parasites & Vectors. 18(1). 125–125. 1 indexed citations

Charles, Samuel, et al.. (2025). Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel against Toxocara canis and Toxascaris leonina infections in dogs. Parasites & Vectors. 18(1). 356–356.

Wiseman, Scott, Hu Li, & Alison S. Tomlin. (2025). Combustion and Emission Performance from the Use of Acid-Catalysed Butanol Alcoholysis Derived Advanced Biofuel Blends in a Compression Ignition Engine. SAE technical papers on CD-ROM/SAE technical paper series. 1. 1 indexed citations

Wiseman, Scott, et al.. (2023). Predicting the physical properties of three-component lignocellulose derived advanced biofuel blends using a design of experiments approach. Sustainable Energy & Fuels. 7(21). 5283–5300. 7 indexed citations

Young, Lisa, et al.. (2021). Effectiveness of Credelio® Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs. Parasites & Vectors. 14(1). 256–256. 4 indexed citations

Wiseman, Scott, et al.. (2021). Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) in juvenile and adult dogs. Parasites & Vectors. 14(1). 285–285.

Wiseman, Scott, et al.. (2021). Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe. Parasites & Vectors. 14(1). 299–299. 6 indexed citations

Young, Lisa, et al.. (2021). Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA. Parasites & Vectors. 14(1). 284–284. 3 indexed citations

10.

Wiseman, Scott, et al.. (2021). Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) against natural intestinal nematode infections in dogs presented as veterinary patients in Europe. Parasites & Vectors. 14(1). 258–258. 3 indexed citations

11.

Snyder, Daniel E., et al.. (2021). Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs. Parasites & Vectors. 14(1). 255–255.

12.

Drake, Jason & Scott Wiseman. (2018). Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013–2016. Parasites & Vectors. 11(1). 39–39. 59 indexed citations

13.

Murphy, Martin, et al.. (2017). A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA. Parasites & Vectors. 10(1). 528–528. 22 indexed citations

14.

Murphy, Martin, Roberto Garcia, Daniela Cavalleri, et al.. (2017). Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America. Parasites & Vectors. 10(1). 523–523. 30 indexed citations

15.

Snyder, Daniel E., Scott Wiseman, & Julian Liebenberg. (2017). Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.. Parasites & Vectors. 10(1). 532–532. 27 indexed citations

16.

Bowman, Dwight D., Craig R. Reinemeyer, Scott Wiseman, & Daniel E. Snyder. (2014). Efficacy of milbemycin oxime in combination with spinosad in the treatment of larval and immature adult stages of Ancylostoma caninum and Toxocara canis in experimentally infected dogs. Veterinary Parasitology. 205(1-2). 134–139. 10 indexed citations

17.

Snyder, Daniel E., et al.. (2013). Speed of kill efficacy and efficacy of flavored spinosad tablets administered orally to cats in a simulated home environment for the treatment and prevention of cat flea (Ctenocephalides felis) infestations. Veterinary Parasitology. 196(3-4). 492–496. 6 indexed citations

18.

Wiseman, Scott, et al.. (2013). Safety and efficacy of spinosad chewable tablets for treatment of flea infestations of cats. Journal of the American Veterinary Medical Association. 242(8). 1092–1098. 14 indexed citations

19.

Wiseman, Scott, et al.. (2011). Confirmation of the efficacy of a combination tablet of spinosad and milbemycin oxime against naturally acquired infections of canine intestinal nematode parasites. Veterinary Parasitology. 184(2-4). 279–283. 18 indexed citations

20.

Snyder, Daniel E., Scott Wiseman, Dwight D. Bowman, John W. McCall, & Craig R. Reinemeyer. (2011). Assessment of the effectiveness of a combination product of spinosad and milbemycin oxime on the prophylaxis of canine heartworm infection. Veterinary Parasitology. 180(3-4). 262–266. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact